Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.3.1 (
Mg2+-ATPase
)
1,484
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Leucine-binding protein described in an earlier paper was examined to characterize the dynamic properties of the system. Leucine-binding protein assembles into a large protein polymer or complex (greater than 302,000 daltons).
Colchicine
reduces and Mg2+ increases the amount of polymer formed. Trypsin destroys the isolated polymer but RNAase and collagenase do not.
Mg2+-ATPase
activity is present in the polymer fraction. The formation of the large complex suggests a quickly adaptable structure capable of responding to ionic and environmental conditions.
...
PMID:Aggregation of binding protein from rat nerve. 72 98
Colchicine
effect has been tested on rat liver plasma membrane-bound enzymes after in vitro or in vivo treatment. It appears that the in vitro treatment does not affect 5'-nucleotidase,
Mg2+-ATPase
and (Na+ + K+)-ATPase, whereas adenylate cyclase is sensitive to both in vitro and in vivo treatment, the latter condition being also effective for 5'-nucleotidase.
...
PMID:Effect of colchicine on rat liver plasma membrane. 610 80